Douangsone Vadysirisack
Corporate Officer/Principal presso DIANTHUS THERAPEUTICS, INC.
Posizioni attive di Douangsone Vadysirisack
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Corporate Officer/Principal | 11/09/2023 | - |
| RA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Storia della carriera di Douangsone Vadysirisack
Formazione di Douangsone Vadysirisack
| The Ohio State University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
Posizioni
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| DIANTHUS THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
